ACT Genomics

Hong Kong-based Prenetics Global Ltd (NASDAQ: PRE) has announced the acquisition of a majority stake in Taiwan-based ACT Genomics Holdings Co., Ltd, aiming to establish a powerhouse Asia-based genomics and precision oncology firm. The transaction involves a USD 20 million cash payment and the issuance of 19.9 million common Prenetics…